13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001846444
Total reported value
$613.5M
$613.5M
20 檔
63.6%
At the close of Q4 2025, Sands Capital Alternatives, LLC disclosed equity holdings valued at approximately $613.5M, spread across 20 reported holdings.
Sands Capital Alternatives, LLC executed strategic sector rebalancing during Q4 2025, establishing 1 new positions while fully exiting 1 holdings and trimming 5 positions.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | KVYO | Klaviyo Inc-a | Stock-Other | 22.86% | -7.19% | +3.83% | |
| 2 | NU | Nu Holdings Ltd. | Stock-Financials | 22.15% | -6.85% | -4.38% | |
| 3 | BBNX | Beta Bionics Inc | Stock-Other | 20.98% | +0.65% | — | |
| 4 | IKT | Inhibikase Therapeutics Inc | Stock-Other | 5.15% | -0.88% | +18.89% | |
| 5 | DASH | Doordash Inc - A | Stock-Consumer Disc | 4.18% | -0.13% | +6.07% | |
| 6 | CPNG | Coupang Inc | Stock-Consumer Disc | 3.96% | -0.78% | +9.49% | |
| 7 | IOT | Samsara Inc-cl A | Stock-Tech | 3.19% | -1.49% | -22.16% | |
| 8 | DDOG | Datadog Inc - Class A | Stock-Tech | 2.25% | +1.03% | -27.73% | |
| 9 | TOST | Toast Inc-class A | Stock-Tech | 2.07% | -0.25% | +92.62% | |
| 10 | BIOA | Bioage Labs Inc | Stock-Other | 2.01% | -0.13% | — | |
| 11 | MNDY | monday.com Ltd. | Stock-Tech | 1.93% | -0.14% | +16.34% | |
| 12 | TTAN | Servicetitan Inc-a | Stock-Tech | 1.85% | -0.10% | — | |
| 13 | TXG | 10x Genomics Inc-class A | Stock-Other | 1.52% | +0.58% | — | |
| 14 | ABOS | Acumen Pharmaceuticals Inc | Stock-Other | 1.39% | -0.46% | — | |
| 15 | TARS | Tarsus Pharmaceuticals Inc | Stock-Other | 1.34% | -0.55% | -50.00% | |
| 16 | ACRV | Acrivon Therapeutics Inc | Stock-Other | 0.99% | -0.04% | — | |
| 17 | SNOW | Snowflake Inc | Stock-Tech | 0.86% | +0.29% | -25.00% | |
| 18 | TSHA | Taysha Gene Therapies Inc | Stock-Other | 0.77% | +0.03% | — | |
| 19 | CADL | Candel Therapeutics Inc | Stock-Other | 0.44% | +0.21% | — | |
| 20 | FIG | Figma Inc-cl A | Stock-Other | 0.13% | -0.02% | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | BBNX | Beta Bionics Inc | +5.4% | — | Unchanged |
| 2 | KVYO | Klaviyo Inc-a | +1.5% | +3.83% | Add |
| 3 | IKT | Inhibikase Therapeutics Inc | +1.3% | +18.89% | Add |
| 4 | BIOA | Bioage Labs Inc | +1% | — | Unchanged |
| 5 | TOST | Toast Inc-class A | +0.8% | +92.62% | Add |
| 6 | TXG | 10x Genomics Inc-class A | +0.3% | — | Unchanged |
| 7 | TSHA | Taysha Gene Therapies Inc | +0.3% | — | Unchanged |
| 8 | ACRV | Acrivon Therapeutics Inc | +0.2% | — | Unchanged |
| 9 | ABOS | Acumen Pharmaceuticals Inc | +0.1% | — | Unchanged |
| 10 | CADL | Candel Therapeutics Inc | 0% | — | Unchanged |
| 11 | FIG | Figma Inc-cl A | -0.1% | — | Unchanged |
| 12 | SNOW | Snowflake Inc | -0.5% | -25.00% | Trim |
| 13 | MNDY | monday.com Ltd. | -0.6% | +16.34% | Add |
| 14 | TARS | Tarsus Pharmaceuticals Inc | -0.9% | -50.00% | Trim |
| 15 | DASH | Doordash Inc - A | -1.2% | +6.07% | Add |
| 16 | DDOG | Datadog Inc - Class A | -1.5% | -27.73% | Trim |
| 17 | CPNG | Coupang Inc | -1.7% | +9.49% | Add |
| 18 | IOT | Samsara Inc-cl A | -1.7% | -22.16% | Trim |
| 19 | NU | Nu Holdings Ltd. | -3% | -4.38% | Trim |
| 20 | TTAN | Servicetitan Inc-a | — | NEW | New buy |
| 21 | CRWD | Crowdstrike Holdings Inc - A | — | EXIT | Sold out |
According to official SEC Form 13F filings, Sands Capital Alternatives, LLC reported a total U.S. public equity portfolio value of $613.5M across 20 disclosed positions in Q4 2025.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including KVYO, NU, BBNX) accounted for 63.6% of total reported equity market value during Q4 2025.
Top New Position Initiated
TTAN
市值: $9.6M
Top Position Liquidated / Trimmed
CRWD
前期市值: $7.7M
During Q4 2025, Sands Capital Alternatives, LLC's top holdings by market value included KVYO (22.9%)、NU (22.1%)、BBNX (21.0%). The largest single position, KVYO, represented 22.9% of total portfolio value.
In Q4 2025, Sands Capital Alternatives, LLC made 13 total portfolio adjustments, initiating 1 new buys, adding to 6 positions, trimming 5 holdings, and fully liquidating 1 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.